News
If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today
Few other investment vehicles have arguably done more to enrich investors than the U.S. stock market. For example, A $5,000 investment in the S&P 500 index executed 10 years ago in 2013 would be
If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today
Few other investment vehicles have arguably done more to enrich investors than the U.S. stock market. For example, A $5,000 investment in the S&P 500 index executed 10 years ago in 2013 would be
Does Abbott Laboratories' Dividend Make It a Buy?
When you're in the market for dividend income, it's important to keep your eye on the long term. An attractive payout today isn't worth much if the company might be forced to reduce or cut its
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
Especially if you're living on a fixed income, being able to bring in even $1,500 in extra money each year via dividends can be a big change for the better. But it's often difficult to figure out
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
Especially if you're living on a fixed income, being able to bring in even $1,500 in extra money each year via dividends can be a big change for the better. But it's often difficult to figure out
Is AbbVie Stock a Buy for Income Investors?
There are very few constants in life. But bills coming in on a routine basis is one of them. This is what makes income investing an appealing strategy for investors to generate the cash flow
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
Dynavax Technologies (NASDAQ: DVAX)Q2 2023 Earnings CallAug 03, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Geron (GERN) Q2 2023 Earnings Call Transcript
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
Why Coherus BioSciences Stock Popped Today
Shares of Coherus BioSciences (NASDAQ: CHRS) soared 17.7% on Thursday, according to data provided by S&P Global Market Intelligence, after the biotech company announced better-than-expected
EQS-News: Invitation to MorphoSys’ Second Quarter and First Half 2023 Financial Results Conference Call on August 10, 2023
EQS-News: Invitation to MorphoSys’ Second Quarter and First Half 2023 Financial Results Conference Call on August 10, 2023
Cigna Group (CI) Q2 2023 Earnings Call Transcript
Humana Foundation Announces 2023 Scholarship Awards
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced 81 winners of college scholarships awarded through the Humana Foundation Scholarship
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The stock market is roaring back in 2023 following a downturn. However, the year hasn't been kind to every company. For instance, drugmakers AbbVie (NYSE: ABBV) and Axsome Therapeutics (NASDAQ:
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the
1 Green Flag and 1 Red Flag for Tilray Stock
Canadian cannabis company Tilray Brands (NASDAQ: TLRY) has been on the right track ever since it merged with rival Aphria in 2021. From an operational standpoint, it had been consistently
3 High-Yielding Dividend Stocks to Buy and Hold for Decades
According to a recent Ipsos poll, one in five Americans don't expect to retire, and that's largely because they don't feel they can afford to do so. One way for Americans to improve their financial
This Is Arguably the Single Best Stock to Buy Right Now
What's the single best stock to buy right now? Ask five different investors and you'll probably get five different answers.
The problem, of course, is that defining what makes a given candidate the
This Is Arguably the Single Best Stock to Buy Right Now
What's the single best stock to buy right now? Ask five different investors and you'll probably get five different answers.
The problem, of course, is that defining what makes a given candidate the